Forecasting The Future: 4 Analyst Projections For Cue Biopharma
Forecasting The Future: 4 Analyst Projections For Cue Biopharma
预测未来：分析师对Cue Biopharma的4项预测
Throughout the last three months, 4 analysts have evaluated Cue Biopharma (NASDAQ:CUE), offering a diverse set of opinions from bullish to bearish.
在过去的三个月中，有4位分析师对Cue Biopharma（纳斯达克股票代码：CUE）进行了评估，提供了从看涨到看跌的不同观点。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级，阐明了过去30天内情绪的变化，并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $8.0, a high estimate of $10.00, and a low estimate of $6.00. This current average has decreased by 7.73% from the previous average price target of $8.67.
分析师分析的12个月目标股价提供了见解，平均目标价为8.0美元，最高估计为10.00美元，低估值为6.00美元。目前的平均价格较之前的平均目标价8.67美元下降了7.73％。
Investigating Analyst Ratings: An Elaborate Study
调查分析师评级：一项详尽的研究
A comprehensive examination of how financial experts perceive Cue Biopharma is derived...
对金融专家如何看待Cue...
登录免费看全文
登录/注册